The DOI matches its Crossref record; 157 of the 157 references it cites were found in a registry or an index.
miRNAs in Cancer (Review of Literature)
Open accessAbstract
MicroRNAs (miRNAs) are short, noncoding, single-stranded RNA molecules that regulate gene expression at the post-transcriptional level by binding to mRNAs. miRNAs affect the course of processes of fundamental importance for the proper functioning of the organism. These processes include cell division, proliferation, differentiation, cell apoptosis and the formation of blood vessels. Altered expression of individual miRNAs has been shown in numerous cancers, which may indicate the oncogenic or suppressor potential of the molecules in question. This paper discusses the current knowledge about the possibility of using miRNA as a diagnostic marker and a potential target in modern anticancer therapies.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
1 retracted
Xiao, J., Yang, B., Lin, H., Lu, Y., Luo, X., & Wang, Z. (2007) · Journal of Cellular Physiology · doi:10.1002/jcp.21062 · Cited by 193
RetractedBartel (2004) · doi:10.1016/s0092-8674(04)00045-5 · Cited by 34,714
The C. elegans heterochronic gene lin-4 encodes small RNAs with antisense complementarity to lin-14
Lee, R. C., Feinbaum, R. L., & Ambros, V. (1993) · Cell · doi:10.1016/0092-8674(93)90529-y · Cited by 12,948
Valadi, H., Ekström, K., Bossios, A., Sjöstrand, M., Lee, J. J., & Lötvall, J. O. (2007) · Nature Cell Biology · doi:10.1038/ncb1596 · Cited by 12,834 · cited 1×
“[110], in their pioneering work, were the first to report on the transport of miRNAs via exosomes, which, functioning as a vehicle for transporting miRNAs between cells, can affect their activity and protein production.”
BackgroundMicroRNA expression profiles classify human cancers
Lu, J., Getz, G., Miska, E. A., Alvarez-Saavedra, E., Lamb, J., Peck, D., Sweet-Cordero, A., Ebert, B. L., Mak, R. H., Ferrando, A. A., et al. (2005) · Nature · doi:10.1038/nature03702 · Cited by 9,539
Circulating microRNAs as stable blood-based markers for cancer detection
Mitchell, P. S., Parkin, R. K., Kroh, E. M., Fritz, B. R., Wyman, S. K., Pogosova-Agadjanyan, E. L., Peterson, A., Noteboom, J., O'Briant, K. C., Allen, A., et al. (2008) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0804549105 · Cited by 7,969
Chen, X., Ba, Y., Ma, L., Cai, X., Yin, Y., Wang, K., Guo, J., Zhang, Y., Chen, J., Guo, X., et al. (2008) · Cell Research · doi:10.1038/cr.2008.282 · Cited by 4,560
Wightman, B., Ha, I., & Ruvkun, G. (1993) · Cell · doi:10.1016/0092-8674(93)90530-4 · Cited by 4,292
Human microRNA genes are frequently located at fragile sites and genomic regions involved in cancers
Calin, G. A., Sevignani, C., Dumitru, C. D., Hyslop, T., Noch, E., Yendamuri, S., Shimizu, M., Rattan, S., Bullrich, F., Negrini, M., et al. (2004) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0307323101 · Cited by 4,095
Dynamic RNA Modifications in Gene Expression Regulation
Roundtree, I. A., Evans, M. E., Pan, T., & He, C. (2017) · Cell · doi:10.1016/j.cell.2017.05.045 · Cited by 3,399
Arroyo, J. D., Chevillet, J. R., Kroh, E. M., Ruf, I. K., Pritchard, C. C., Gibson, D. F., Mitchell, P. S., Bennett, C. F., Pogosova-Agadjanyan, E. L., Stirewalt, D. L., et al. (2011) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1019055108 · Cited by 3,294
Causes and consequences of microRNA dysregulation in cancer
Croce, C. M. (2009) · Nature Reviews Genetics · doi:10.1038/nrg2634 · Cited by 2,998
microRNAs as oncogenes and tumor suppressors
Zhang, B., Pan, X., Cobb, G. P., & Anderson, T. A. (2007) · Developmental Biology · doi:10.1016/j.ydbio.2006.08.028 · Cited by 2,749
The role of MicroRNAs in human cancer
Peng, Y., & Croce, C. M. (2016) · Signal Transduction and Targeted Therapy · doi:10.1038/sigtrans.2015.4 · Cited by 2,483
The MicroRNA Spectrum in 12 Body Fluids
Weber, J. A., Baxter, D. H., Zhang, S., Huang, D. Y., How Huang, K., Jen Lee, M., Galas, D. J., & Wang, K. (2010) · Clinical Chemistry · doi:10.1373/clinchem.2010.147405 · Cited by 2,477
MicroRNA biogenesis pathways in cancer
Lin, S., & Gregory, R. I. (2015) · Nature Reviews Cancer · doi:10.1038/nrc3932 · Cited by 2,112
Characterization of extracellular circulating microRNA
Turchinovich, A., Weiz, L., Langheinz, A., & Burwinkel, B. (2011) · Nucleic Acids Research · doi:10.1093/nar/gkr254 · Cited by 1,941
Lawrie, C. H., Gal, S., Dunlop, H. M., Pushkaran, B., Liggins, A. P., Pulford, K., Banham, A. H., Pezzella, F., Boultwood, J., Wainscoat, J. S., et al. (2008) · British Journal of Haematology · doi:10.1111/j.1365-2141.2008.07077.x · Cited by 1,735
Serum MicroRNAs Are Promising Novel Biomarkers
Gilad, S., Meiri, E., Yogev, Y., Benjamin, S., Lebanony, D., Yerushalmi, N., Benjamin, H., Kushnir, M., Cholakh, H., Melamed, N., et al. (2008) · PLoS ONE · doi:10.1371/journal.pone.0003148 · Cited by 1,347
Exosomal MicroRNA: A Diagnostic Marker for Lung Cancer
Rabinowits, G., Gerçel-Taylor, C., Day, J. M., Taylor, D. D., & Kloecker, G. H. (2009) · Clinical Lung Cancer · doi:10.3816/clc.2009.n.006 · Cited by 1,262
Target mRNAs are repressed as efficiently by microRNA-binding sites in the 5′ UTR as in the 3′ UTR
Lytle, J. R., Yario, T. A., & Steitz, J. A. (2007) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0703820104 · Cited by 1,196
RNAi therapeutics: Principles, prospects and challenges
Aagaard, L., & Rossi, J. J. (2007) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2007.03.005 · Cited by 895
MicroRNAs as Oncogenes and Tumor Suppressors
Chen, C.-Z. (2005) · New England Journal of Medicine · doi:10.1056/nejmp058190 · Cited by 758
MicroRNAs and Other Tiny Endogenous RNAs in C. elegans
Ambros, V., Lee, R. C., Lavanway, A., Williams, P. T., & Jewell, D. (2003) · Current Biology · doi:10.1016/s0960-9822(03)00287-2 · Cited by 706
Resnick, K. E., Alder, H., Hagan, J. P., Richardson, D. L., Croce, C. M., & Cohn, D. E. (2009) · Gynecologic Oncology · doi:10.1016/j.ygyno.2008.08.036 · Cited by 647
A Protein Sensor for siRNA Asymmetry
Tomari, Y., Matranga, C., Haley, B., Martinez, N., & Zamore, P. D. (2004) · Science · doi:10.1126/science.1102755 · Cited by 599
An estimate of the total number of true human miRNAs
Alles, J., Fehlmann, T., Fischer, U., Backes, C., Galata, V., Minet, M., Hart, M., Abu-Halima, M., Grässer, F. A., Lenhof, H.-P., et al. (2019) · Nucleic Acids Research · doi:10.1093/nar/gkz097 · Cited by 567
Identifying miRNAs, targets and functions
Liu, B., Li, J., & Cairns, M. J. (2014) · Briefings in Bioinformatics · doi:10.1093/bib/bbs075 · Cited by 563
Circulating MicroRNAs: a novel class of biomarkers to diagnose and monitor human cancers
Zen, K., & Zhang, C. (2012) · Medicinal Research Reviews · doi:10.1002/med.20215 · Cited by 502
microRNA Therapeutics in Cancer — An Emerging Concept
Shah, M. Y., Ferrajoli, A., Sood, A. K., Lopez-Berestein, G., & Calin, G. A. (2016) · EBioMedicine · doi:10.1016/j.ebiom.2016.09.017 · Cited by 453
MicroRNA Biomarkers in Whole Blood for Detection of Pancreatic Cancer
Schultz, N. A., Dehlendorff, C., Jensen, B. V., Bjerregaard, J. K., Nielsen, K. R., Bojesen, S. E., Calatayud, D., Nielsen, S. E., Yilmaz, M., Holländer, N. H., et al. (2014) · JAMA · doi:10.1001/jama.2013.284664 · Cited by 450
MicroRNA-21 induces resistance to 5-fluorouracil by down-regulating human DNA MutS homolog 2 (hMSH2)
Valeri, N., Gasparini, P., Braconi, C., Paone, A., Lovat, F., Fabbri, M., Sumani, K. M., Alder, H., Amadori, D., Patel, T., et al. (2010) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1015541107 · Cited by 382
Circulating miRNAs: cell–cell communication function?
Turchinovich, A., Samatov, T. R., Tonevitsky, A. G., & Burwinkel, B. (2013) · Frontiers in Genetics · doi:10.3389/fgene.2013.00119 · Cited by 371
The Regulatory Role of MicroRNAs in Breast Cancer
Loh, H.-Y., Norman, B. P., Lai, K.-S., Rahman, N. M. A. N. A., Alitheen, N. B. M., & Osman, M. A. (2019) · International Journal of Molecular Sciences · doi:10.3390/ijms20194940 · Cited by 326
Zhang, H., Yang, L., Zhu, Y., Yao, X., Zhang, S., Dai, B., Zhu, Y., Shen, Y., Shi, G., & Ye, D. (2011) · The Prostate · doi:10.1002/pros.21246 · Cited by 322
Ma, J., Dong, C., & Ji, C. (2010) · Cancer Gene Therapy · doi:10.1038/cgt.2010.18 · Cited by 303
Silva, J., García, V., Zaballos, Á., Provencio, M., Lombardía, L., Almonacid, L., García, J. M., Domínguez, G., Peña, C., Diaz, R., et al. (2011) · European Respiratory Journal · doi:10.1183/09031936.00029610 · Cited by 280
Complexity of the microRNA repertoire revealed by next-generation sequencing
Lee, L. W., Zhang, S., Etheridge, A., Ma, L., Martin, D., Galas, D., & Wang, K. (2010) · RNA · doi:10.1261/rna.2225110 · Cited by 279
MicroRNA replacement therapy in cancer
Mollaei, H., Safaralizadeh, R., & Rostami, Z. (2019) · Journal of Cellular Physiology · doi:10.1002/jcp.28058 · Cited by 262
Yu, Y., Zeng, D., Ou, Q., Liu, S., Li, A., Chen, Y., Lin, D., Gao, Q., Zhou, H., Liao, W., et al. (2019) · JAMA Network Open · doi:10.1001/jamanetworkopen.2019.6879 · Cited by 261
Profiling of circulating microRNAs: from single biomarkers to re-wired networks
Zampetaki, A., Willeit, P., Drozdov, I., Kiechl, S., & Mayr, M. (2012) · Cardiovascular Research · doi:10.1093/cvr/cvr266 · Cited by 258
MicroRNA Signatures: Novel Biomarker for Colorectal Cancer?
Luo, X., Burwinkel, B., Tao, S., & Brenner, H. (2011) · Cancer Epidemiology, Biomarkers & Prevention · doi:10.1158/1055-9965.epi-11-0035 · Cited by 242
Circulating microRNAs (miRNA) in Serum of Patients With Prostate Cancer
Mahn, R., Heukamp, L. C., Rogenhofer, S., von Ruecker, A., Müller, S. C., & Ellinger, J. (2011) · Urology · doi:10.1016/j.urology.2011.01.020 · Cited by 240
MicroRNA Biomarkers for Infectious Diseases: From Basic Research to Biosensing
Tribolet, L., Kerr, E., Cowled, C., Bean, A. G. D., Stewart, C. R., Dearnley, M., & Farr, R. J. (2020) · Frontiers in Microbiology · doi:10.3389/fmicb.2020.01197 · Cited by 222
Zhang, W., Dahlberg, J. E., & Tam, W. (2007) · The American Journal of Pathology · doi:10.2353/ajpath.2007.070070 · Cited by 221
Clinical impact of circulating miR-221 in plasma of patients with pancreatic cancer
Kawaguchi, T., Komatsu, S., Ichikawa, D., Morimura, R., Tsujiura, M., Konishi, H., Takeshita, H., Nagata, H., Arita, T., Hirajima, S., et al. (2013) · British Journal of Cancer · doi:10.1038/bjc.2012.546 · Cited by 214
Dysregulation of miR-15a and miR-214 in human pancreatic cancer
Zhang, X. J., Ye, H., Zeng, C. W., He, B., Zhang, H., & Chen, Y. Q. (2010) · Journal of Hematology & Oncology · doi:10.1186/1756-8722-3-46 · Cited by 196
Lentivirus-mediated antagomir expression for specific inhibition of miRNA function
Scherr, M., Venturini, L., Battmer, K., Schaller-Schoenitz, M., Schaefer, D., Dallmann, I., Ganser, A., & Eder, M. (2007) · Nucleic Acids Research · doi:10.1093/nar/gkm971 · Cited by 190
Cavallari, I., Ciccarese, F., Sharova, E., Urso, L., Raimondi, V., Silic-Benussi, M., D’Agostino, D. M., & Ciminale, V. (2021) · Cancers · doi:10.3390/cancers13235874 · Cited by 188
Dysregulation of circulating microRNAs and prediction of aggressive prostate cancer
Shen, J., Hruby, G. W., McKiernan, J. M., Gurvich, I., Lipsky, M. J., Benson, M. C., & Santella, R. M. (2012) · The Prostate · doi:10.1002/pros.22499 · Cited by 183
A panel of five circulating microRNAs as potential biomarkers for prostate cancer
Chen, Z., Zhang, G., Li, H., Luo, J., Li, Z., Chen, G., & Yang, J. (2012) · The Prostate · doi:10.1002/pros.22495 · Cited by 183
Kan, C. W., Hahn, M. A., Gard, G. B., Maidens, J., Huh, J. Y., Marsh, D. J., & Howell, V. M. (2012) · BMC Cancer · doi:10.1186/1471-2407-12-627 · Cited by 182
Role of microRNAs in breast cancer
Singh, R., & Mo, Y.-Y. (2013) · Cancer Biology & Therapy · doi:10.4161/cbt.23296 · Cited by 173
Multifunctional Aptamer-miRNA Conjugates for Targeted Cancer Therapy
Esposito, C. L., Cerchia, L., Catuogno, S., De Vita, G., Dassie, J. P., Santamaria, G., Swiderski, P., Condorelli, G., Giangrande, P. H., & de Franciscis, V. (2014) · Molecular Therapy · doi:10.1038/mt.2014.5 · Cited by 169
Zhang, J., Song, Y., Zhang, C., Zhi, X., Fu, H., Ma, Y., Chen, Y., Pan, F., Wang, K., Ni, J., et al. (2015) · Theranostics · doi:10.7150/thno.10305 · Cited by 168
Serum microRNAs are promising novel biomarkers for diffuse large B cell lymphoma
Fang, C., Zhu, D.-X., Dong, H.-J., Zhou, Z.-J., Wang, Y.-H., Liu, L., Fan, L., Miao, K.-R., Liu, P., Xu, W., et al. (2012) · Annals of Hematology · doi:10.1007/s00277-011-1350-9 · Cited by 164
Locked Nucleic Acid Oligonucleotides: The Next Generation of Antisense Agents?
Gr??nweller, A., & Hartmann, R. K. (2007) · BioDrugs · doi:10.2165/00063030-200721040-00004 · Cited by 164
Zhong, S., Golpon, H., Zardo, P., & Borlak, J. (2021) · Translational Research · doi:10.1016/j.trsl.2020.11.012 · Cited by 158
The role of miRNAs in colorectal cancer progression and chemoradiotherapy
Zhang, N., Hu, X., Du, Y., & Du, J. (2020) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2020.111099 · Cited by 158
MicroRNA-21 in Pancreatic Ductal Adenocarcinoma Tumor-Associated Fibroblasts Promotes Metastasis
Kadera, B. E., Li, L., Toste, P. A., Wu, N., Adams, C. E., Dawson, D. W., & Donahue, T. R. (2013) · PLoS ONE · doi:10.1371/journal.pone.0071978 · Cited by 155
Stahlhut, C. E., & Slack, F. J. (2015) · Cell Cycle · doi:10.1080/15384101.2014.1003008 · Cited by 155
Oncogenic MicroRNAs: Key Players in Malignant Transformation
Frixa, T., Donzelli, S., & Blandino, G. (2015) · Cancers · doi:10.3390/cancers7040904 · Cited by 153
Circulating microRNAs in Hepatocellular Carcinoma: Potential Diagnostic and Prognostic Biomarkers
Mirzaei, H. R., Sahebkar, A., Mohammadi, M., Yari, R., Salehi, H., Jafari, M., Namdar, A., Khabazian, E., Jaafari, M. R., & Mirzaei, H. (2016) · Current Pharmaceutical Design · doi:10.2174/1381612822666160303110838 · Cited by 151
microRNA Replacement Therapy for Cancer
Henry, J. C., Azevedo‐Pouly, A. C. P., & Schmittgen, T. D. (2011) · Pharmaceutical Research · doi:10.1007/s11095-011-0548-9 · Cited by 150
Using artificial microRNA sponges to achieve microRNA loss-of-function in cancer cells
Tay, F. C., Lim, J. K., Zhu, H., Hin, L. C., & Wang, S. (2014) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2014.05.010 · Cited by 148
Synergistic action of the microRNA‐17 polycistron and Myc in aggressive cancer development
Tagawa, H., Karube, K., Tsuzuki, S., Ohshima, K., & Seto, M. (2007) · Cancer Science · doi:10.1111/j.1349-7006.2007.00531.x · Cited by 148
MicroRNA-34a inhibits migration and invasion of colon cancer cells via targeting to Fra-1
Wu, J., Wu, G., Lv, L., Ren, Y.-F., Zhang, X., Xue, Y.-F., Li, G., Lu, X., Sun, Z. S., & Tang, K. (2011) · Carcinogenesis · doi:10.1093/carcin/bgr304 · Cited by 145
Novel blood-based microRNA biomarker panel for early diagnosis of pancreatic cancer
Ganepola, G. A. P., Rutledge, J. R., Suman, P., Yiengpruksawan, A., & Chang, D. H. (2014) · World Journal of Gastrointestinal Oncology · doi:10.4251/wjgo.v6.i1.22 · Cited by 141
Candidate miRNAs in human breast cancer biomarkers: a systematic review
Adhami, M., Haghdoost, A. A., Sadeghı, B., & Afshar, R. M. (2017) · Breast Cancer · doi:10.1007/s12282-017-0814-8 · Cited by 141
Circulating miR-378 in plasma: a reliable, haemolysis-independent biomarker for colorectal cancer
Zanutto, S., Pizzamiglio, S., Ghilotti, M., Bertan, C. M., Ravagnani, F., Perrone, F., Leo, E., Pilotti, S., Verderio, P., Gariboldi, M., et al. (2014) · British Journal of Cancer · doi:10.1038/bjc.2013.819 · Cited by 135
Small but influential: the role of microRNAs on gene regulatory network and 3′UTR evolution
Zhang, R., & Su, B. (2009) · Journal of genetics and genomics/Journal of Genetics and Genomics · doi:10.1016/s1673-8527(09)60001-1 · Cited by 131
Zhao, G., Zhang, J., Shi, Y., Qin, Q., Liu, Y., Wang, B., Tian, K., Deng, S., Li, X., Zhu, S., et al. (2013) · PLoS ONE · doi:10.1371/journal.pone.0073803 · Cited by 130
Prognostic Significance of miR-215 in Colon Cancer
Karaayvaz, M., Pal, T., Song, B., Zhang, C., Georgakopoulos, P., Mehmood, S., Burke, S., Shroyer, K., & Ju, J. (2011) · Clinical Colorectal Cancer · doi:10.1016/j.clcc.2011.06.002 · Cited by 130
Li, Y., Cai, B., Shen, L., Dong, Y., Lu, Q., Sun, S., Liu, S., Ma, S., Ma, P. X., & Chen, J. (2017) · Cancer Letters · doi:10.1016/j.canlet.2017.03.032 · Cited by 129
Chai, H., Liu, M., Tian, R., Li, X., & Tang, H. (2011) · Acta Biochimica et Biophysica Sinica · doi:10.1093/abbs/gmq125 · Cited by 114
Nanoscale delivery systems for microRNAs in cancer therapy
Boca, S., Gulei, D., Zimța, A., Onaciu, A., Magdo, L., Țigu, A. B., Ionescu, C., Irimie, A., Buiga, R., & Berindan‐Neagoe, I. (2019) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-019-03317-9 · Cited by 110
MicroRNA as tools and therapeutics in lung cancer
Barger, J. F., & Nana-Sinkam, S. P. (2015) · Respiratory Medicine · doi:10.1016/j.rmed.2015.02.006 · Cited by 108
Role of miRNA sponges in hepatocellular carcinoma
Li, D., Zhang, J., & Li, J. (2019) · Clinica Chimica Acta · doi:10.1016/j.cca.2019.09.013 · Cited by 108
Zhou, Q. Y., Huang, S., Zhang, F., Li, S., Liu, C., Xi, Y., Wang, L., Wang, X., He, Q., Sun, C., et al. (2017) · Cell Proliferation · doi:10.1111/cpr.12394 · Cited by 107
Let-7 microRNA as a potential therapeutic target with implications for immunotherapy
Gilles, M.-E., & Slack, F. J. (2018) · Expert Opinion on Therapeutic Targets · doi:10.1080/14728222.2018.1535594 · Cited by 107
Zhang, Y., Zhang, Y., Yin, Y., & Li, S. (2019) · Pathology - Research and Practice · doi:10.1016/j.prp.2019.152466 · Cited by 106
Circulating miR-200c and miR-141 and outcomes in patients with breast cancer
Antolín, S., Calvo, L., Blanco, M., Santiago, M. P., Lorenzo-Patiño, M. J., Haz‐Conde, M., Santamarina, I., Figueroa, A., Antón-Aparicio, L. M., & Valladares‐Ayerbes, M. (2015) · BMC Cancer · doi:10.1186/s12885-015-1238-5 · Cited by 105
Oncogenic and tumor suppressive roles of microRNAs in apoptosis and autophagy
Chen, Y., Fu, L., Wen, X., Liu, B., Huang, J. M., Wang, J. ‐., & Wei, Y. (2014) · APOPTOSIS · doi:10.1007/s10495-014-0999-7 · Cited by 101
Epigenetic IVD Tests for Personalized Precision Medicine in Cancer
Beltrán-García, J., Osca-Verdegal, R., Mena, S., & García‐Giménez, J. L. (2019) · Frontiers in Genetics · doi:10.3389/fgene.2019.00621 · Cited by 95
miRNAs in the Diagnosis and Prognosis of Skin Cancer
Neagu, M. T., Constantin, C., Creţoiu, S. M., & Zurac, S. (2020) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2020.00071 · Cited by 93
Underexpression of miR-224 in methotrexate resistant human colon cancer cells
Mencia-Trinchant, N., Selga, E., Noé, V., & Ciudad, C. J. (2011) · Biochemical Pharmacology · doi:10.1016/j.bcp.2011.08.009 · Cited by 85
Micolucci, L., Akhtar, M. M., Olivieri, F., Rippo, M. R., & Procopio, A. D. (2016) · Oncotarget · doi:10.18632/oncotarget.9686 · Cited by 85
MicroRNA and colorectal cancer
Corté, H., Manceau, G., Blons, H., & Laurent‐Puig, P. (2011) · Digestive and Liver Disease · doi:10.1016/j.dld.2011.10.010 · Cited by 82
Current status and implications of microRNAs in ovarian cancer diagnosis and therapy
Zaman, M. S., Maher, D. M., Khan, S., Jaggi, M., & Chauhan, S. C. (2012) · Journal of Ovarian Research · doi:10.1186/1757-2215-5-44 · Cited by 81
Nedaeinia, R., Sharifi, M., Avan, A., Kazemi, M., Rafiee, L., Ghayour‐Mobarhan, M., & Salehi, R. (2016) · Cancer Gene Therapy · doi:10.1038/cgt.2016.25 · Cited by 81
Small Non-Coding RNAs as Novel Therapeutics
Roßbach, M. (2010) · Current Molecular Medicine · doi:10.2174/156652410791317048 · Cited by 79
MicroRNAs: potential biomarkers for diagnosis and prognosis of different cancers
Sharma, P. C., & Gupta, A. (2020) · Translational Cancer Research · doi:10.21037/tcr-20-1294 · Cited by 79
Aptamer-miRNA-212 Conjugate Sensitizes NSCLC Cells to TRAIL
Iaboni, M., Russo, V. M., Fontanella, R., Roscigno, G., Fiore, D., Donnarumma, E., Esposito, C. L., Quintavalle, C., Giangrande, P. H., de Franciscis, V., et al. (2016) · Molecular Therapy — Nucleic Acids · doi:10.1038/mtna.2016.5 · Cited by 76
A Highly Effective and Long-Lasting Inhibition of miRNAs with PNA-Based Antisense Oligonucleotides
Oh, S. Y., Ju, Y., & Park, H. (2009) · Molecules and Cells · doi:10.1007/s10059-009-0134-8 · Cited by 75
MicroRNAs as Modulators of Oral Tumorigenesis—A Focused Review
Rishabh, K., Khadilkar, S., Kumar, A., Kalra, I., Kumar, A. P., & Kunnumakkara, A. B. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22052561 · Cited by 75
Let-7a microRNA functions as a potential tumor suppressor in human laryngeal cancer
Liu, J. (2009) · Oncology Reports · doi:10.3892/or_00000554 · Cited by 74
Kumar, S., Sharawat, S. K., Ali, A., Gaur, V., Malik, P. S., Kumar, S., Mohan, A., & Guleria, R. (2020) · Current Problems in Cancer · doi:10.1016/j.currproblcancer.2020.100540 · Cited by 73
Diagnostic role of circulating MiR-21 in colorectal cancer: a update meta-analysis
Liu, T., Liu, D., Guan, S., & Dong, M. (2020) · Annals of Medicine · doi:10.1080/07853890.2020.1828617 · Cited by 73
Non-coding RNAs: Therapeutic Strategies and Delivery Systems
Ling, H. Y. (2016) · Advances in experimental medicine and biology · doi:10.1007/978-3-319-42059-2_12 · Cited by 72
Kim, M. W., Park, S., Lee, H., Gwak, H., Hyun, K., Kim, J. Y., Jung, H., & Kim, S. I. (2021) · Cancer Science · doi:10.1111/cas.15155 · Cited by 67
Chen, W., Cao, R., Su, W., Zhang, X., Xu, Y., Wang, P., Gan, Z., Xie, Y., Li, H., & Qin, J. (2021) · Lab on a Chip · doi:10.1039/d0lc01311k · Cited by 66
Circulating miRNA as Biomarkers for Colorectal Cancer Diagnosis and Liver Metastasis
Nassar, F. J., Msheik, Z. S., Itani, M. M., Helou, R. E., Hadla, R., Kreidieh, F., Bejjany, R., Mukherji, D., Shamseddine, A. I., Nasr, R., et al. (2021) · Diagnostics · doi:10.3390/diagnostics11020341 · Cited by 64
Nguyen, H. T., Kacimi, S. E. O., Nguyen, T. L., Suman, K. H., Lemus-Martin, R., Saleem, H., & Do, D. N. (2021) · Biology · doi:10.3390/biology10050417 · Cited by 64
Piao, Y., Piao, M., & Ryu, K. H. (2016) · Computers in Biology and Medicine · doi:10.1016/j.compbiomed.2016.11.008 · Cited by 63
Krieger, T., Pearson, I. V., Bell, J. A., Doherty, J. P., & Robbins, P. B. (2020) · Diagnostic Pathology · doi:10.1186/s13000-020-0927-9 · Cited by 63
Dokhanchi, M., Pakravan, K., Zareian, S., Hussen, B. M., Farid, M., Razmara, E., Mohammadi, M. M., Cho, W. C. S., & Babashah, S. (2021) · Life Sciences · doi:10.1016/j.lfs.2021.119937 · Cited by 63
Amirfallah, A., Knútsdóttir, H., Arason, A., Hilmarsdóttir, B., Johannsson, O. T., Agnarsson, B. A., Barkardottir, R. B., & Reynisdóttir, I. (2021) · PLoS ONE · doi:10.1371/journal.pone.0260327 · Cited by 62
Kashyap, D., & Kaur, H. (2020) · Life Sciences · doi:10.1016/j.lfs.2020.117417 · Cited by 61
The miR-34a-5p promotes the multi-chemoresistance of osteosarcoma via repression of the AGTR1 gene
Pu, Y., Zhao, F., Li, Y., Cui, M., Wang, H., Meng, X., & Cai, S. (2017) · BMC Cancer · doi:10.1186/s12885-016-3002-x · Cited by 60
The functional sites of miRNAs and lncRNAs in gastric carcinogenesis
Wan, X., Ding, X., Chen, S., Song, H., Jiang, H., Fang, Y., Li, P., & Guo, J. (2015) · Tumor Biology · doi:10.1007/s13277-015-3136-5 · Cited by 58
Maminezhad, H., Ghanadian, S., Pakravan, K., Razmara, E., Rouhollah, F., Mohammadi, M. M., & Babashah, S. (2020) · Life Sciences · doi:10.1016/j.lfs.2020.118226 · Cited by 57
Itani, M. M., Nassar, F. J., Tfayli, A., Talhouk, R., Chamandi, G., Itani, A. R., Makoukji, J., Boustany, R., Hou, L., Zgheib, N. K., et al. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22116121 · Cited by 57
MicroRNAs: Novel Diagnostic and Therapeutic Tools for Pancreatic Ductal Adenocarcinoma?
Mardin, W. A., & Mees, S. T. (2009) · Annals of Surgical Oncology · doi:10.1245/s10434-009-0623-1 · Cited by 55
A nanoparticle formula for delivering siRNA or miRNAs to tumor cells in cell culture and in vivo
Choi, K. Y., Silvestre, Ó. F., Huang, X., Hida, N., Liu, G., Ho, D. N., Lee, S., Lee, S. W., Hong, J. I., & Chen, X. S. (2014) · Nature Protocols · doi:10.1038/nprot.2014.128 · Cited by 54
Circulating microRNAs: Promising Biomarkers Involved in Several Cancers and Other Diseases
Zhao, Y., Song, Y., Li, Y., Song, G., & Teng, C. (2017) · DNA and Cell Biology · doi:10.1089/dna.2016.3426 · Cited by 53
Kong, Y., Zou, S., Yang, F., Xu, X., Bu, W., Jia, J., & Liu, Z. (2016) · Cancer Letters · doi:10.1016/j.canlet.2016.07.038 · Cited by 52
An Aptamer Targeting the Apical‐Loop Domain Modulates pri‐miRNA Processing
Weinberg, C. E., Michlewski, G., Hopp, C. S., Rentmeister, A., Cáceres, J. F., Famulok, M., & Mayer, G. (2010) · Angewandte Chemie International Edition · doi:10.1002/anie.200906919 · Cited by 50
Zedan, A. H., Hansen, T. F., Assenholt, J., Plečkaitis, M., Madsen, J. S., & Osther, P. J. S. (2018) · Tumor Biology · doi:10.1177/1010428318775864 · Cited by 50
Tian, L., Shan, W., Zhang, Y., Lv, X., Li, X., & Wei, C. (2015) · Pathology & Oncology Research · doi:10.1007/s12253-015-9979-7 · Cited by 49
Li, Y., Zhang, L., Dong, Z., Xu, H., Yan, L., Wang, W., Chen, T., Chen, C., Wang, W., Yang, Q., et al. (2021) · Pathology - Research and Practice · doi:10.1016/j.prp.2021.153405 · Cited by 49
Amodeo, V., Bazan, V., Fanale, D., Insalaco, L., Caruso, S., Cicero, G., Bronte, G., Rolfo, C. D., Santini, D., & Russo, A. D. (2013) · Expert Opinion on Therapeutic Targets · doi:10.1517/14728222.2013.832206 · Cited by 48
A Universal Aptamer Chimera for the Delivery of Functional microRNA-126
Rohde, J.-H., Weigand, J. E., Suess, B., & Dimmeler, S. (2015) · Nucleic Acid Therapeutics · doi:10.1089/nat.2014.0501 · Cited by 44
Synthetic Pre-miRNA-Based shRNA as Potent RNAi Triggers
Terasawa, K., Shimizu, K., & Tsujimoto, G. (2011) · Journal of Nucleic Acids · doi:10.4061/2011/131579 · Cited by 42
Xu, Y., Ou, M., Keough, E., Roberts, J., Koeplinger, K., Lyman, M., Fauty, S. E., Carlini, E., Stern, M., Zhang, R., et al. (2014) · Molecular Pharmaceutics · doi:10.1021/mp400584h · Cited by 42
A review of expression profiling of circulating microRNAs in men with prostate cancer
Kelly, B. D., Miller, N., Healy, N. A., Walsh, K., & Kerin, M. J. (2012) · British Journal of Urology · doi:10.1111/j.1464-410x.2012.11244.x · Cited by 41
Emerging role of microRNAs in diagnosis and treatment of various diseases including ovarian cancer
Shah, P. P., Hutchinson, L., & Kakar, S. S. (2009) · Journal of Ovarian Research · doi:10.1186/1757-2215-2-11 · Cited by 41
Development of a miRNA-seq based prognostic signature in lung adenocarcinoma
Siriwardhana, C., Khadka, V. S., Chen, J. J., & Deng, Y. (2019) · BMC Cancer · doi:10.1186/s12885-018-5206-8 · Cited by 38
Wen, W., Mai, S., Lin, H., Zhang, M., Huang, J., Hua, X., Lin, C., Long, Z., Lu, Z.-J., Sun, X., et al. (2019) · Journal of Translational Medicine · doi:10.1186/s12967-019-1923-2 · Cited by 38
Amide-Modified RNA: Using Protein Backbone to Modulate Function of Short Interfering RNAs
Kotikam, V., & Rozners, E. (2020) · Accounts of Chemical Research · doi:10.1021/acs.accounts.0c00249 · Cited by 38
Serum-based microRNAs: Are we blinded by potential?
Jackson, D. (2008) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0809999106 · Cited by 36
Liu, Z., Wu, H., Zhu, J., & Miao, H. (2014) · BMC Bioinformatics · doi:10.1186/1471-2105-15-336 · Cited by 36
Farré, P. L., Duca, R. B., Massillo, C., Dalton, G. N., Graña, K. D., Gardner, K. L., Lacunza, E., & Siervi, A. D. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms222011135 · Cited by 31
Wu, W., Liu, S., Liang, Y., Zhou, Z., & Liu, X. (2017) · Cancer Cell International · doi:10.1186/s12935-017-0386-x · Cited by 28
Wang, D., Feng, M., Ma, X., Tao, K., & Wang, G. (2021) · Life Sciences · doi:10.1016/j.lfs.2021.119398 · Cited by 28
Tan, W., Liang, G., Xie, X., Jiang, W. G., Tan, L., Sanders, A. J., Liu, Z., Ling, Y., Zhong, W., Tian, Z., et al. (2019) · The Oncologist · doi:10.1634/theoncologist.2018-0697 · Cited by 27
Li, M., Li, Q., Yin, Q., Wang, Y., Shang, J., & Wang, L. H. (2020) · Clinical & Translational Oncology · doi:10.1007/s12094-020-02501-9 · Cited by 26
Kim, J. (2021) · Diagnostics · doi:10.3390/diagnostics11010107 · Cited by 26
Circulating RNA in Kidney Cancer: What We Know and What We Still Suppose
Cinque, A., Vago, R., & Trevisani, F. (2021) · Genes · doi:10.3390/genes12060835 · Cited by 26
Non-nucleotide Modification of Anti-miRNA Oligonucleotides
Lennox, K. A., Vakulskas, C. A., & Behlke, M. A. (2016) · Methods in molecular biology · doi:10.1007/978-1-4939-6563-2_3 · Cited by 25
Liu, X., Chang, Q., Wang, H., Qian, H., & Jiang, Y. (2021) · Breast Cancer · doi:10.1007/s12282-021-01215-2 · Cited by 24
Faversani, A., Favero, C., Dioni, L., Pesatori, A. C., Bollati, V., Montoli, M., Musso, V., Terrasi, A., Fusco, N., Nosotti, M., et al. (2021) · Frontiers in Oncology · doi:10.3389/fonc.2021.643280 · Cited by 24
The Multifaceted Role and Utility of MicroRNAs in Indolent B-Cell Non-Hodgkin Lymphomas
Artemaki, P. I., Letsos, P. A., Zoupa, I. C., Katsaraki, K., Karousi, P., Papageorgiou, S. G., Pappa, V., Scorilas, A., & Kontos, C. K. (2021) · Biomedicines · doi:10.3390/biomedicines9040333 · Cited by 23
Tanno, T., Zhang, P., Lazarski, C. A., Liu, Y., & Zheng, P. (2017) · Blood Advances · doi:10.1182/bloodadvances.2017004705 · Cited by 22
Ahadi, A. (2021) · Immunogenetics · doi:10.1007/s00251-020-01201-6 · Cited by 22
Sharma, B., Randhawa, V., Vaiphei, K., Gupta, V., Dahiya, D., & Agnihotri, N. (2021) · The Journal of Steroid Biochemistry and Molecular Biology · doi:10.1016/j.jsbmb.2021.105822 · Cited by 22
Yi, M., Liao, Z., Deng, L., Xu, L., Tan, Y. L., Liu, K., Chen, Z., & Zhang, Y. (2021) · Annals of Medicine · doi:10.1080/07853890.2021.2000634 · Cited by 20
Circulating microRNA-92a-3p in colorectal cancer: a review
Yamada, N. O., & Senda, T. (2021) · Medical Molecular Morphology · doi:10.1007/s00795-021-00282-w · Cited by 17
Zaniani, N. R., Oroujalian, A., Valipour, A., & Peymani, M. (2021) · Molecular Biology Reports · doi:10.1007/s11033-021-06623-3 · Cited by 17
Balatti, V., Oghumu, S., Bottoni, A., Maharry, K. S., Cascione, L., Fadda, P., Parwani, A. V., Croce, C. M., & Iwenofu, O. H. (2018) · Head and Neck Pathology · doi:10.1007/s12105-018-0971-x · Cited by 16
Monastirioti, A. A., Papadaki, C., Rounis, K., Kalapanida, D., Mavroudis, D., & Agelaki, S. (2021) · Cells · doi:10.3390/cells10081988 · Cited by 15
Zhao, G., Zhang, J., Shi, Y., Qin, Q., Liu, Y., Wang, B., Tian, K., Deng, S., Li, X., Zhu, S., et al. (2013) · PLoS ONE · doi:10.1371/annotation/497d9208-190a-44b7-ac27-aea12183f47c · Cited by 14
Ibrahiem, A. T., Fawzy, M. S., Alsel, B. T. A., & Toraih, E. A. (2020) · Journal of Clinical Laboratory Analysis · doi:10.1002/jcla.23679 · Cited by 12
Zhu, L.-R., Yuan, R.-X., Xia, X.-B., Wang, Y., Zhu, Y.-M., Fi, L., & Li, J. (2021) · Cancer Biomarkers · doi:10.3233/cbm-210090 · Cited by 12
Daniela Gerovska, D., García-Gallastegui, P., Crende, O., Márquez, J., Larrinaga, G., Unzurrunzaga, M., Araúzo-Bravo, M. J., & Badiola, I. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22094819 · Cited by 11
Zhang, R., Liu, P., Zhang, X., Ye, Y., & Yu, J. (2021) · Annals of Translational Medicine · doi:10.21037/atm-21-2124 · Cited by 8
Perception of breast cancer risk factors: Dysregulation of TGF-β/miRNA axis in Pakistani females
Ahmed, F., Adnan, M., Malik, A. M., Tariq, S., Kamal, F., & Ijaz, B. (2021) · PLoS ONE · doi:10.1371/journal.pone.0255243 · Cited by 8
Calvo-López, T., Paz-Cabezas, M., Llovet, P., Ibáñez, M. D., Sastre, J., Alonso-Orduña, V., Viéitez, J. M., Yubero, A., Vera, R., Asensio-Martínez, E., et al. (2021) · Cancer Biomarkers · doi:10.3233/cbm-210353 · Cited by 7
Cited by
MicroRNA: trends in clinical trials of cancer diagnosis and therapy strategies
Kim, T., & Croce, C. M. (2023) · Experimental & Molecular Medicine · doi:10.1038/s12276-023-01050-9 · Cited by 407
Trials and Tribulations of MicroRNA Therapeutics
Seyhan, A. A. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms25031469 · Cited by 381
Metadata
- Authors
- Smolarz, B., Durczyński, A., Romanowicz, H., Szyłło, K., & Hogendorf, P.
- Venue
- International Journal of Molecular Sciences
- Publisher
- MDPI AG
- Published
- 2022-03-03
- Volume
- 23
- Issue
- 5
- Pages
- 2805
- ISSN
- 1422-0067 (ISSN-L)
- OpenAlex
- W4214906265
- Cited by
- 296
- References
- 157
- FWCI
- 20.00
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.